BIAF prices $3.2M offering — 4.0M shares or pre-funded warrants at $0.80; close ~Jun 18
AI Summary
BioAffinity (BIAF / BIAFW) priced a public offering of 4,000,000 common shares (or pre-funded warrants) at $0.80 per share (pre-funded warrant price $0.793) for aggregate gross proceeds of $3.2M, with WallachBeth Capital as sole placement agent. The offering is expected to close on or about June 18, 2026, so dilution will occur at closing; the pre-funded warrants are immediately exercisable upon issuance. Timing: The press release does not indicate dilution today; initial share dilution occurs at the offering close (Jun 18, 2026), and once the offering closes those shares have been issued.
Positives
- Gross proceeds of $3.2M before agent fees and expenses
- Pre-funded warrants are immediately exercisable, allowing purchasers to receive shares at closing
Negatives
- 4,000,000 shares (or equivalent) will be added to the cap table at closing, increasing share supply
- No anchor investors or cornerstone commitments disclosed in the announcement
Filing Context
Filing and Dilution Context
Earliest dilution
Earliest dilution: Jun 18, 2026 close
Dilution status
delayed
Dilution timing
Dilution status: Delayed
Trigger type
closing
Trigger date
Jun 18, 2026